The PIK3CA gene is mutated with high frequency in human breast cancers

Cancer Biology and Therapy

Volumn 3, Issue 8, 2004, Pages 772-775

  Bachman, Kurtis E ^a   Argani, Pedram ^a   Samuels, Yardena ^a   Silliman, Natalie ^a   Ptak, Janine ^a   Szabo, Steve ^a   Konishi, Hiroyuki ^a   Karakas, Bedri ^a   Blair, Brian G ^a   Lin, Clarence ^a   Peters, Brock A ^a   Velculescu, Victor E ^a   Park, Ben Ho ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Breast cancer; Mutation; Oncogene; PI3 kinase; PIK3CA

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PIK3CA PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CONTROLLED STUDY; GENE LOCATION; GENE MUTATION; HUMAN; HUMAN TISSUE; ONCOGENE; PROTEIN DOMAIN; SOMATIC MUTATION; BREAST; BREAST TUMOR; CANCER INVASION; CELL CULTURE; COMPARATIVE STUDY; ENZYMOLOGY; EXON; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MISSENSE MUTATION; PATHOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BREAST; BREAST NEOPLASMS; EXONS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MUTATION, MISSENSE; NEOPLASM INVASIVENESS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 16644393213     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.8.994     Document Type: Article

References (15)

1. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296:1655-7.
2. Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, et al. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology. Proc Natl Acad Sci USA 1998; 95:14821-6.
3. Blaustein M, Pelisch F, Coso OA, Bissell MJ, Kornblihtt AR, Srebrow A. Mammary epithelial-mesenchy mal interaction regulates fibronectin alternative splicing via phosphatidylinositol 3-kinase. J Biol Chem 2004; In Press.
4. Liu H, Radisky DC, Wang F, Bissell MJ. Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J Cell Biol 2004; 164:603-12.
5. Horowitz JC, Lee DY, Waghray M, Keshamouni VG, Thomas PE, Zhang H, et al. Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J Biol Chem 2004; 279:1359-67.
6. Kang P, Svoboda KK. PI-3 kinase activity is required for epithelial-mesenchymal transformation during palate fusion. Dev Dyn 2002; 225:316-21.
7. Knuefermann C, Lu Y, Liu B, Jin W, Liang K, Wu L, et al. HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells. Oncogene 2003; 22:3205-12.
8. Liang K, Jin W, Knuefermann C, Schmidt M, Mills GB, Ang KK, et al. Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy. Mol Cancer Ther 2003; 2:353-60.
9. Liang K, Lu Y, Jin W, Ang KK, Milas L, Fan Z. Sensitization of breast cancer cells to radiation by trastuzumab. Mol Cancer Ther 2003; 2:1113-20.
10. Zhou H, Kim YS, Peletier A, McCall W, Earp HS, Sartor CI. Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance. Int J Radiat Oncol Biol Phys 2004; 58:344-52.
11. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 1999; 21:99-102.
12. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, et al. High Frequency of Mutations of the PIK3CA Gene in Human Cancers. Science 2004; 304:554.
13. Shih IM, Wang TL, Traverso G, Romans K, Hamilton SR, Ben-Sasson S, et al. Top-down morphogenesis of colorectal tumors. Proc Natl Acad Sci USA 2001; 98:2640-5.
14. Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001; 344:276-85.
15. Ross JS, Fletcher JA, Bloom KJ, Linette GP, Stec J, Stmmans WF, et al. Targeted therapy in breast cancer: The HER-2/neu gene and protein. Mol Cell Proteomics 2004; In Press.